Locations
New York, NY, USA · North America
industry
Biotechnology · Community and Lifestyle · DeepTech · Health
Size
51-200 employees
Stage
Series B
founded in
2019
Helaina is a biotechnology company that specializes in replicating functional proteins found in the human body, particularly through its product effera™ Human Lactoferrin. Founded in 2019, Helaina aims to create a new category of bioactive proteins that enhance nutrition for all phases of life. The company has developed a technology platform that allows for the production of these proteins at scale, ensuring high quality and safety through rigorous clinical studies. With a focus on advancing human healthspan, Helaina is positioned to disrupt the nutrition market by providing innovative, science-backed products that offer immune benefits and nutritional options similar to those found in breast milk.
Something looks off?On-site & Remote